Portable Microfluidic Pathogen Detection System
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic tools for infectious diseases, particularly in developing countries, face challenges in rapid detection and reporting due to the need for centralized laboratories, which delays treatment and quarantine measures, and there is a lack of portable and cost-effective solutions for point-of-care testing.
Innovation Solution
A portable diagnostic system that includes a sample carrier with microfluidic chambers, a detection instrument with optical interrogation capabilities, and a smartphone-based platform for real-time imaging and data analysis, enabling rapid nucleic acid amplification and detection of viral, bacterial, or fungal pathogens at the point of care.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If centralized laboratory testing is used for pathogen detection, then measurement precision and reliability are improved, but loss of time and device complexity increase significantly
Solution Approach 1:
The patent extracts the core nucleic acid amplification function from centralized laboratories and implements it in portable point-of-care devices. The microfluidic chip contains all necessary reagents and amplification chambers, allowing pathogen detection to be performed locally without sending samples to centralized facilities, thereby reducing diagnosis time while maintaining detection accuracy through standardized amplification protocols
Solution Approach 2:
The patent employs isothermal amplification methods that maintain constant temperature (e.g., 65°C) rather than requiring thermal cycling between multiple temperatures. This parameter change simplifies the device requirements, allowing use of simple heating blocks instead of complex thermal cyclers, and enables rapid amplification in portable devices while preserving detection sensitivity
2Ease of operation
If portable point-of-care testing devices are developed, then loss of time is reduced and ease of operation is improved, but device complexity and manufacturing precision requirements increase
Solution Approach 1:
The patent divides the diagnostic system into modular components: a disposable microfluidic chip containing pre-loaded reagents and amplification chambers, a simple external heating device, and a detection system. This segmentation allows the complex microfluidic functions to be pre-assembled and quality-controlled during manufacturing, while the user only needs to perform simple sample loading and result reading, thereby improving ease of operation without sacrificing functionality
Solution Approach 2:
The patent pre-loads all necessary reagents (polymerase, dNTPs, primers, buffers) into the microfluidic chambers during manufacturing before the device reaches the user. This preliminary action eliminates the need for users to handle or prepare complex reagent mixtures, significantly simplifying operation while allowing the device to maintain full diagnostic capability through pre-configured amplification systems
3Adaptability or versatility
If multiplexed detection of multiple pathogens is implemented, then adaptability is improved and loss of information is reduced, but device complexity and measurement precision requirements increase
Solution Approach 1:
The patent designs the microfluidic chip with multiple independent amplification chambers, each containing primers specific to different pathogens (e.g., influenza A, influenza B, RSV). This universal design allows a single device to detect multiple pathogens simultaneously through parallel amplification reactions, improving adaptability while maintaining detection sensitivity through standardized fluorescence readout for each chamber
Solution Approach 2:
The patent uses identical microfluidic chamber designs and fluorescence detection methods for each pathogen target, creating replicated detection units. Each chamber is a copy of the amplification system with pathogen-specific primers, allowing multiplexed detection through parallel identical systems. This copying approach maintains measurement precision by using the same validated detection methodology for each pathogen while increasing versatility
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This system allows for immediate detection and reporting of infectious diseases, facilitating timely treatment and quarantine, and can be used in resource-limited settings, reducing the burden on centralized laboratories and improving public health surveillance.
Implementation Method 1
Each of the light sources is configured to illuminate the microfluidic chambers disposed at the working position with excitation light, and a fluorophore in the nucleic acid amplification medium is configured to emit fluorescence light indicative of nucleic acid amplification in response to the excitation light
Data Source
AI summary
A sample carrier may include a sample preparation module and an amplification module. A sample mixes with a lysis medium and a nucleic acid amplification medium in the sample preparation module and then flows into a plurality of microfluidic chambers in the amplification module. The microfluidic chambers have disposed therein primers configured to initiate amplification of one or more target nucleic acid sequences corresponding to one or more pathogens. The sample carrier is inserted into an apparatus that includes a plurality of Sight sources and a camera. The light sources illuminate the microfluidic chambers with excitation light, a fluorophore emits fluorescence light indicative of nucleic acid amplification in response to the excitation-light, and the camera captures images of the microfluidic chambers. A target nucleic acid sequence in the sample is indicated by the images showing an increasing fluorescence in a microfluidic chamber that has the primers for that sequence.